Table 1.
Baseline characterisitcs of the study GO patients.
| Parameters | Values | |
|---|---|---|
| Patients, n | 323 | |
| Age, year | 48.97 ± 14.77 | |
| Sex, male/female | 56/267 | |
| Smokers, (positive)% | 22.22 | |
| Duration of GO, year | 7.12 ± 6.66 | |
| Diplopia, (positive)% | 3.15 | |
| Asymmetry, (positive) % | 18.63 | |
| PROPTOSIS, mm | ||
| Right eye | 17.95 ± 3.71 | |
| Left eye | 17.94 ± 3.6 | |
| LID FISSURE WIDTH, mm | ||
| Right eye | 9.56 ± 1.95 | |
| Left eye | 9.64 ± 1.98 | |
| CAS SCORE, n | ||
| 0–1 | 246 | |
| 2–5 | 77 | |
| NO SPECS SCORE, n | ||
| 0–1 | 204 | |
| 2–4 | 119 | |
| EUGOGO, n | ||
| Mild | 229 | |
| Moderate to Severe | 94 | |
| Serum TSH (mU/L) | 2.39 ± 1.27 | |
| Serum Ft4 (ng/dL) | 1.21 ± 0.33 | |
| Serum TRAb (positive) % | 91.8 | |
| Antithyroid drug therapy, n | 248 | |
| Radioiodine therapy, n | 70 | |
| Thyroidectomy, n | 5 | |
GO, Graves' orbitopathy; TRAb; CAS, clinical activity score; NO SPECS, EUGOGO; values are given as number (n), percentages (%), and mean ± standard deviation.